Richard Taylor
Atlanta, GANPI 1033154158
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $673 and has fallen 95.0% since, to $34 in 2021.
Across 63 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$274
- Amgen$199
- Therapeuticsmd, Inc.$108
- Bayer$102
- AMAG Pharmaceuticals, Inc.$72
- Astellas Pharma US Inc$70
- plus $334 from 14 others
What the payments were for
- Food & beverage$1,11296%
- Education$464%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 15 | $274 |
| Amgen | 7 | $199 |
| Therapeuticsmd, Inc. | 6 | $108 |
| Bayer | 6 | $102 |
| AMAG Pharmaceuticals, Inc. | 4 | $72 |
| Astellas Pharma US Inc | 4 | $70 |
| Pfizer | 3 | $46 |
| Hologic Sales And Service, LLC | 3 | $44 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Johnson & Johnson | 1 | $32 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| Merck | 2 | $27 |
| Boston Scientific | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $19 |
| Avanos Medical | 1 | $16 |
| Medicem Inc. | 1 | $16 |
| Covidien LP | 1 | $15 |
| Coopersurgical, Inc. | 1 | $15 |
| Dysis Medical, Inc. | 1 | $13 |
| Mission Pharmacal Company | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.